Insider · CIK 0001231845

EASTHAM KARIN

Reports to the SEC for 11 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001231845

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-18	VCYTVERACYTE, INC.S Sale	Director	SSale	−3,200 sh	$52.78	−$169K	15,626
2026-06-18	VCYTVERACYTE, INC.S Sale	Director	SSale	−529 sh	$53.55	−$28.3K	15,097
2026-06-11	VCYTVERACYTE, INC.A Award	Director	AAward	+5,272 sh	—	—	18,826
2026-05-12	PSNLPersonalis, Inc. · Stock Option (right to buy)A Award	Director	AAward	+37.5K sh	—	—	37,500
2026-05-12	PSNLPersonalis, Inc.A Award	Director	AAward	+6,250 sh	—	—	22,366
2026-05-12	PSNLPersonalis, Inc.A Award	Director	AAward	+6,250 sh	—	—	19,756
2025-12-05	VCYTVERACYTE, INC.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$7.94	+$79.4K	23,554
2025-12-05	VCYTVERACYTE, INC.S Sale	Director	SSale	−6,392 sh	$44.52	−$285K	27,162
2025-12-05	VCYTVERACYTE, INC.S Sale	Director	SSale	−12.8K sh	$45.84	−$587K	14,354
2025-12-05	VCYTVERACYTE, INC. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	0
2025-12-05	VCYTVERACYTE, INC. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	0
2025-12-05	VCYTVERACYTE, INC.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$7.60	+$76K	33,554
2025-12-05	VCYTVERACYTE, INC.S Sale	Director	SSale	−800 sh	$46.59	−$37.3K	13,554
2025-11-05	VCYTVERACYTE, INC.S Sale	Director	SSale	−9,674 sh	$40.02	−$387K	13,554
2025-06-18	VCYTVERACYTE, INC.A Award	Director	AAward	+9,321 sh	—	—	23,228
2025-06-13	VCYTVERACYTE, INC.S Sale	Director	SSale	−4,590 sh	$26.66	−$122K	13,907
2025-05-16	PSNLPersonalis, Inc. · Stock Option (right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2025-01-02	VCYTVERACYTE, INC. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	0
2025-01-02	VCYTVERACYTE, INC.S Sale	Director	SSale	−4,691 sh	$40.50	−$190K	18,497
2025-01-02	VCYTVERACYTE, INC.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$5.28	+$52.8K	28,497
2025-01-02	VCYTVERACYTE, INC.S Sale	Director	SSale	−5,309 sh	$40.12	−$213K	23,188
2024-11-19	VCYTVERACYTE, INC.S Sale	Director	SSale	−3,006 sh	$37.77	−$114K	28,622
2024-11-19	VCYTVERACYTE, INC.S Sale	Director	SSale	−10.1K sh	$38.76	−$392K	18,497
2024-11-19	VCYTVERACYTE, INC.S Sale	Director	SSale	−1,600 sh	$36.77	−$58.8K	31,628
2024-07-16	VCYTVERACYTE, INC.S Sale	Director	SSale	−7,500 sh	$25.00	−$188K	33,228
2024-06-13	VCYTVERACYTE, INC.A Award	Director	AAward	+11.5K sh	—	—	40,728
2024-06-11	VCYTVERACYTE, INC.S Sale	Director	SSale	−3,870 sh	$20.59	−$79.7K	29,255
2024-06-07	VCYTVERACYTE, INC.S Sale	Director	SSale	−2,500 sh	$20.97	−$52.4K	33,125
2024-06-07	VCYTVERACYTE, INC.M Exercise/Conversion	Director	MExercise/Conversion	+2,500 sh	$10.41	+$26K	35,625
2024-06-07	VCYTVERACYTE, INC. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,500 sh	—	—	7,500
2024-05-17	PSNLPersonalis, Inc. · Stock Option (right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2024-04-01	VCYTVERACYTE, INC. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	$13.19	−$132K	0
2024-04-01	VCYTVERACYTE, INC.S Sale	Director	SSale	−10K sh	$21.65	−$217K	33,125
2024-04-01	VCYTVERACYTE, INC.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$13.19	+$132K	43,125
2023-06-09	VCYTVERACYTE, INC.A Award	Director	AAward	+9,674 sh	—	—	33,125
2023-05-17	PSNLPersonalis, Inc. · Stock Option (right to buy)A Award	Director	AAward	+40K sh	—	—	40,000
2023-03-16	VCYTVERACYTE, INC. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−18.8K sh	—	—	0
2023-03-16	VCYTVERACYTE, INC.S Sale	Director	SSale	−18.8K sh	$22.78	−$427K	23,451
2023-03-16	VCYTVERACYTE, INC.M Exercise/Conversion	Director	MExercise/Conversion	+18.8K sh	$12.12	+$227K	42,201
2023-02-28	VCYTVERACYTE, INC. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	18,750
2023-02-28	VCYTVERACYTE, INC.S Sale	Director	SSale	−10K sh	$25.00	−$250K	23,451
2023-02-28	VCYTVERACYTE, INC.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$12.12	+$121K	33,451
2023-01-13	GERNGERON CORPM Exercise/Conversion	Director	MExercise/Conversion	+35K sh	$1.10	+$38.5K	109,047
2023-01-13	GERNGERON CORP · Stock Options (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−35K sh	—	—	0
2022-09-16	NKTRNEKTAR THERAPEUTICS · Stock OptionA Award	Director	AAward	+20.4K sh	—	—	20,400
2022-09-16	NKTRNEKTAR THERAPEUTICSA Award	Director	AAward	+10.2K sh	—	—	23,233
2022-09-13	NKTRNEKTAR THERAPEUTICSS Sale	Director	SSale	−21.3K sh	$3.61	−$76.8K	13,033
2022-06-16	VCYTVERACYTE, INC.A Award	Director	AAward	+14.7K sh	—	—	23,451
2022-05-17	PSNLPersonalis, Inc. · Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,035
2022-05-17	PSNLPersonalis, Inc.A Award	Director	AAward	+10.8K sh	—	—	13,506

Recent filings

Accepted (ET)
Jun 224
EASTHAM KARIN0001231845-26-000006
SEC(opens sec.gov)
Jun 154
EASTHAM KARIN0001231845-26-000004
SEC(opens sec.gov)
Jun 114/A
EASTHAM KARIN0001231845-26-000002
SEC(opens sec.gov)
May 144
EASTHAM KARIN0001231845-26-000001
SEC(opens sec.gov)
Dec 84
EASTHAM KARIN0001231845-25-000007
SEC(opens sec.gov)
Nov 74
EASTHAM KARIN0001231845-25-000005
SEC(opens sec.gov)
Jun 234
EASTHAM KARIN0001384101-25-000099
SEC(opens sec.gov)
Jun 174
EASTHAM KARIN0001384101-25-000080
SEC(opens sec.gov)
May 204
EASTHAM KARIN0001415889-25-013797
SEC(opens sec.gov)
Jan 64
EASTHAM KARIN0001384101-25-000002
SEC(opens sec.gov)

Companies

Address

6000 SHORELINE COURT SUITE 300

SOUTH SAN FRANCISCO, CA, 94080